Pulmonary Hypertension - Related Resources

Cochrane reviews

Intravenous prostacyclin over 12 weeks appears to improve exercise capacity, NYHA functional class and several cardiopulmonary haemodynamic variables in patients with pulmonary hypertension Prostacyclin for Pulmonary Hypertension.

Klinger JR, Elliott CG, Levine DJ et al. Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report. Chest 2019;155(3):565-586. [PubMed]
Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009;30(20):2493-537. [PubMed]
McLaughlin VV, Archer SL, Badesch DB et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009 Apr 28;53(17):1573-619. [PubMed]

Archer SL, Michelakis ED. Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension. N Engl J Med 2009 Nov 5;361(19):1864-71. [PubMed]

Primary/Secondary Keywords